Ishida Takashi, Miki Atsushi, Sakuma Yasunaru, Watanabe Jun, Endo Kazuhiro, Sasanuma Hideki, Teratani Takumi, Kitayama Joji, Sata Naohiro
Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
Cancers (Basel). 2024 May 30;16(11):2087. doi: 10.3390/cancers16112087.
Osteopenia is a well-known risk factor for survival in patients with hepatocellular carcinoma; however, it is unclear whether osteopenia can apply to both genders and how osteopenia is associated with cancer progression. The aim of this study was to elucidate whether osteopenia predicts reduced survival in regression models in both genders and whether osteopenia is associated with the pathological factors associated with reduced survival.
This study included 188 consecutive patients who underwent hepatectomy. Bone mineral density was assessed using computed tomography (CT) scan images taken within 3 months before surgery. Non-contrast CT scan images at the level of the 11th thoracic vertebra were used. The cutoff value of osteopenia was calculated using a threshold value of 160 Hounsfield units. Overall survival (OS) curves and recurrence-free survival (RFS) were constructed using the Kaplan-Meier method, as was a log-rank test for survival. The hazard ratio and 95% confidence interval for overall survival were calculated using Cox's proportional hazard model.
In the regression analysis, age predicted bone mineral density. The association in females was greater than that in males. The OS and RFS of osteopenia patients were shorter than those for non-osteopenia patients. According to univariate and multivariate analyses, osteopenia was an independent risk factor for OS and RFS. The sole pathological factor associated with osteopenia was microvascular portal vein invasion.
Models suggest that osteopenia may predict decreased OS and RFS in patients undergoing resection of hepatocellular carcinoma due to the mechanisms mediated via microvascular portal vein invasion.
骨量减少是肝细胞癌患者生存的一个众所周知的危险因素;然而,尚不清楚骨量减少是否适用于男女两性,以及骨量减少与癌症进展如何相关。本研究的目的是阐明在回归模型中骨量减少是否可预测男女两性生存率降低,以及骨量减少是否与生存率降低相关的病理因素有关。
本研究纳入了188例连续接受肝切除术的患者。使用术前3个月内拍摄的计算机断层扫描(CT)图像评估骨密度。采用第11胸椎水平的非增强CT扫描图像。骨量减少的临界值使用160亨氏单位的阈值计算得出。采用Kaplan-Meier法构建总生存(OS)曲线和无复发生存(RFS)曲线,并进行生存的对数秩检验。使用Cox比例风险模型计算总生存的风险比和95%置信区间。
在回归分析中,年龄可预测骨密度。女性中的相关性大于男性。骨量减少患者的OS和RFS短于非骨量减少患者。根据单因素和多因素分析,骨量减少是OS和RFS的独立危险因素。与骨量减少相关的唯一病理因素是门静脉微血管侵犯。
模型表明,由于通过门静脉微血管侵犯介导的机制,骨量减少可能预测肝细胞癌切除患者的OS和RFS降低。